Terbinafine HCl USP

Composition : Terbinafine USP 250 mg as Terbinafine Hydrochloride Tablet.

Indication : Mycofree tablet is indicated for the treatment of : Onychomycosis of fingernails and toenails due to dermatophytes. Fungal infections of the skin (Tinea corporis, Tinea cruris, Tinea pedis). Hair and scalp infections (Tinea capitis). Yeast infections of the skin caused by the genus Candida (e.g. Candida albicans), where oral therapy is generally considered appropriate owing to the site, severity or extent of the infection.

Dosage and administration : For Tinea cruris: 250mg tablet once daily for 2 to 4 weeks. For Tinea pedis: 250mg tablet once daily for 2 to 6 weeks. For Tinea corporis: 250mg tablet once daily for 4 weeks. For dermatophyte infections of the finger & toenails : 250mg tablet once daily for 6 to 12 weeks. Longer treatment is necessary for toenail infections. For skin and hair infections : 250mg tablet once daily for 2 to 6 weeks. Or, as directed by the registered physician.

Use in pregnancy and lactation : Pregnancy : Pregnancy category B. It should not be used during pregnancy unless the potential benefits clearly outweigh the risk. Lactation : It should not be given to nursing mothers because the drug is excreted in breast milk.

Packing: 1x10’s tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.